Oxford BioMedica Plc (OXB) - Financial and Strategic SWOT Analysis Review

September 2021 | 79 pages | ID: O4CE347A8F1EN
GlobalData

Abstracts

Oxford BioMedica Plc (OXB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oxford BioMedica Plc (Oxford Biomedica) is a biopharmaceutical company involved in the development and commercialization of gene-based medicines. It has LentiVector, a sector leading lentiviral vector delivery platform. Based on this platform the company has developed a portfolio of gene and cell therapy product candidates in ophthalmology, oncology, central nervous system (CNS) and other therapy areas. It has partnership and license agreement with other companies to develop potential gene and cell therapy products. The company has presence in different locations in Oxfordshire, the UK. Oxford BioMedica is headquartered in Oxford, the UK.

Oxford BioMedica Plc Key Recent Developments

Jul 15,2021: Oxford Biomedica appoints Dr. Michael Hayden as Non-Executive Director
May 27,2021: Oxford BioMedica: Board change
May 27,2021: Oxford Biomedica announce Board Change
May 18,2021: Oxford Biomedica upgrades financial guidance for supply agreement with AstraZeneca for manufacture of COVID-19 Vaccine
Apr 27,2021: Oxford Biomedica Announces Annual General Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Oxford BioMedica Plc - Key Facts
Oxford BioMedica Plc - Key Employees
Oxford BioMedica Plc - Key Employee Biographies
Oxford BioMedica Plc - Major Products and Services
Oxford BioMedica Plc - History
Oxford BioMedica Plc - Company Statement
Oxford BioMedica Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Oxford BioMedica Plc - Business Description
Other Break-up: Bioprocessing/Commercial Development
Performance
Other Break-up: Licence Fees, Milestones and Royalties
Performance
Other Break-up: Platform
Overview
Performance
Other Break-up: Product
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
R&D Overview
Oxford BioMedica Plc - Corporate Strategy
Oxford BioMedica Plc - SWOT Analysis
SWOT Analysis - Overview
Oxford BioMedica Plc - Strengths
Oxford BioMedica Plc - Weaknesses
Oxford BioMedica Plc - Opportunities
Oxford BioMedica Plc - Threats
Oxford BioMedica Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Oxford BioMedica Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 15, 2021: Oxford Biomedica appoints Dr. Michael Hayden as Non-Executive Director
May 27, 2021: Oxford BioMedica: Board change
May 27, 2021: Oxford Biomedica announce Board Change
May 18, 2021: Oxford Biomedica upgrades financial guidance for supply agreement with AstraZeneca for manufacture of COVID-19 Vaccine
Apr 27, 2021: Oxford Biomedica Announces Annual General Meeting
Apr 15, 2021: Oxford Biomedica announces Preliminary results for the year ended 31 December 2020
Apr 06, 2021: Oxford Biomedica signs a new three year Development & Supply Agreement with Boehringer Ingelheim for the manufacture and supply of viral vectors
Feb 03, 2021: Oxford Biomedica: Board changes
Jan 18, 2021: Prime Minister Boris Johnson formally opens Oxford Biomedica's manufacturing facility Oxbox
Nov 23, 2020: Oxford Biomedica appoints Dr. Sam Rasty as Non-Executive Director

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Oxford BioMedica Plc, Key Facts
Oxford BioMedica Plc, Key Employees
Oxford BioMedica Plc, Key Employee Biographies
Oxford BioMedica Plc, Major Products and Services
Oxford BioMedica Plc, History
Oxford BioMedica Plc, Other Locations
Oxford BioMedica Plc, Subsidiaries
Oxford BioMedica Plc, Key Competitors
Oxford BioMedica Plc, Ratios based on current share price
Oxford BioMedica Plc, Annual Ratios
Oxford BioMedica Plc, Annual Ratios (Cont...1)
Oxford BioMedica Plc, Annual Ratios (Cont...2)
Oxford BioMedica Plc, Interim Ratios
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Oxford BioMedica Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Oxford BioMedica Plc, Performance Chart (2016 - 2020)
Oxford BioMedica Plc, Ratio Charts
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021